NYMC Faculty Publications
Correction To: Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: Pooled Results From Three 5-Week, Randomized, Double-Blind, Placebo-Controlled, EMERGENT Trials (Schizophrenia, (2024), 10, 1, (102), 10.1038/S41537-024-00525-6)
Author Type(s)
Faculty
DOI
10.1038/s41537-025-00595-0
Journal Title
Schizophrenia
Document Type
Article
Publication Date
12-1-2025
Department
Psychiatry and Behavioral Sciences
Disciplines
Medicine and Health Sciences
Abstract
Correction to: Schizophreniahttps://doi.org/10.1038/s41537-024-00525-6, published online 02 November 2024 In the original version of this article, in Table 2, the difference for the PANSS total score was incorrect and should have been −9.9. In the methods section under “Statistical methods,” the text should have read: “participants who received ≥1 dose of study medication and had a baseline and at…”. Additionally, the text should have read: “..treatment groups and visit, baseline PANSS total score, age, sex, and trial…”. In the results section under “Efficacy,” the PANSS positive subscale data should have been formatted as “PANSS positive subscale score (95% CI –4.1, –2.4; p < 0.0001;…)”. This has been corrected in the original article.
Recommended Citation
Kaul, I., Sawchak, S., Claxton, A., Sauder, C., Hassman, H., Kakar, R., Walling, D., Citrome, L., Zhu, H., Miller, A., & Brannan, S. (2025). Correction To: Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: Pooled Results From Three 5-Week, Randomized, Double-Blind, Placebo-Controlled, EMERGENT Trials (Schizophrenia, (2024), 10, 1, (102), 10.1038/S41537-024-00525-6). Schizophrenia, 11 (1). https://doi.org/10.1038/s41537-025-00595-0
